OtherResearch
Mycoplasma Clearance and Risk Analysis in a Model Bioprocess: Robustness with Respect to Mycoplasma Species
Talia Faison, Julie Wang, Sarah Johnson, Matthew Brown, Meng-Jung Chiang, Sherri Dolan, Carl Breuning, Sai Rashmika Velugula-Yellela, Scott Lute, Erica J. Fratz-Berilla and Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology September 2019, pdajpst.2018.009613; DOI: https://doi.org/10.5731/pdajpst.2018.009613
Talia Faison
1 CDER/FDA;
Julie Wang
1 CDER/FDA;
Sarah Johnson
1 CDER/FDA;
Matthew Brown
1 CDER/FDA;
Meng-Jung Chiang
1 CDER/FDA;
Sherri Dolan
2 Sartorius Stedim North America
Carl Breuning
2 Sartorius Stedim North America
Sai Rashmika Velugula-Yellela
1 CDER/FDA;
Scott Lute
1 CDER/FDA;
Erica J. Fratz-Berilla
1 CDER/FDA;
Kurt Brorson
1 CDER/FDA;
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Mycoplasma Clearance and Risk Analysis in a Model Bioprocess: Robustness with Respect to Mycoplasma Species
Talia Faison, Julie Wang, Sarah Johnson, Matthew Brown, Meng-Jung Chiang, Sherri Dolan, Carl Breuning, Sai Rashmika Velugula-Yellela, Scott Lute, Erica J. Fratz-Berilla, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2019, pdajpst.2018.009613; DOI: 10.5731/pdajpst.2018.009613
Mycoplasma Clearance and Risk Analysis in a Model Bioprocess: Robustness with Respect to Mycoplasma Species
Talia Faison, Julie Wang, Sarah Johnson, Matthew Brown, Meng-Jung Chiang, Sherri Dolan, Carl Breuning, Sai Rashmika Velugula-Yellela, Scott Lute, Erica J. Fratz-Berilla, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2019, pdajpst.2018.009613; DOI: 10.5731/pdajpst.2018.009613
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
More in this TOC Section
Similar Articles